BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X902. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $47,496,283 | +373.7% | 1,875,100 | +478.2% | 0.01% | +450.0% |
Q1 2024 | $10,027,356 | -51.2% | 324,300 | -36.2% | 0.00% | -60.0% |
Q4 2023 | $20,532,182 | +72.9% | 508,600 | +13.0% | 0.01% | +25.0% |
Q3 2023 | $11,871,774 | +31.5% | 450,200 | -14.2% | 0.00% | +33.3% |
Q2 2023 | $9,026,560 | +72.7% | 524,800 | +66.5% | 0.00% | +50.0% |
Q1 2023 | $5,226,016 | +3819.0% | 315,200 | +1701.1% | 0.00% | – |
Q4 2022 | $133,350 | -85.0% | 17,500 | -80.4% | 0.00% | – |
Q3 2022 | $887,000 | -40.3% | 89,200 | -45.5% | 0.00% | -100.0% |
Q2 2022 | $1,487,000 | – | 163,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 99,800 | $906,000 | 0.00% |
SIMPLEX TRADING, LLC | 89,700 | $814,000 | 0.00% |
JANE STREET GROUP, LLC | 163,800 | $1,487,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |